Barclays Lowers Centene (NYSE:CNC) Price Target to $91.00

Centene (NYSE:CNC) had its target price reduced by Barclays from $97.00 to $91.00 in a research report report published on Tuesday, Benzinga reports. They currently have an overweight rating on the stock.

Other research analysts have also issued reports about the stock. Robert W. Baird cut their price objective on shares of Centene from $83.00 to $66.00 and set a “neutral” rating on the stock in a report on Friday, October 25th. Stephens reaffirmed an “equal weight” rating and set a $78.00 price target on shares of Centene in a research note on Monday, August 5th. Deutsche Bank Aktiengesellschaft upped their price objective on Centene from $82.00 to $87.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 target price on shares of Centene in a report on Tuesday, October 1st. Finally, StockNews.com lowered Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $84.00.

Centene Price Performance

Shares of NYSE:CNC opened at $62.26 on Tuesday. The business has a fifty day simple moving average of $71.55 and a 200-day simple moving average of $72.02. Centene has a 52 week low of $59.77 and a 52 week high of $81.42. The company has a market cap of $32.75 billion, a P/E ratio of 10.81, a P/E/G ratio of 0.85 and a beta of 0.48. The company has a quick ratio of 1.17, a current ratio of 1.10 and a debt-to-equity ratio of 0.64.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. EP Wealth Advisors LLC lifted its holdings in Centene by 1.0% in the 1st quarter. EP Wealth Advisors LLC now owns 13,604 shares of the company’s stock worth $1,068,000 after buying an additional 133 shares in the last quarter. WR Wealth Planners LLC increased its position in shares of Centene by 41.4% during the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock worth $31,000 after acquiring an additional 137 shares during the last quarter. Whittier Trust Co. boosted its holdings in Centene by 10.0% in the second quarter. Whittier Trust Co. now owns 1,562 shares of the company’s stock valued at $104,000 after purchasing an additional 142 shares during the last quarter. Fidelis Capital Partners LLC grew its stake in Centene by 5.0% during the 1st quarter. Fidelis Capital Partners LLC now owns 3,316 shares of the company’s stock valued at $260,000 after purchasing an additional 158 shares in the last quarter. Finally, Mount Yale Investment Advisors LLC raised its position in shares of Centene by 2.1% in the 3rd quarter. Mount Yale Investment Advisors LLC now owns 8,082 shares of the company’s stock valued at $608,000 after purchasing an additional 167 shares in the last quarter. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.